Highest-materiality recent filing
Board size increased from one to four directors effective April 1, 2026.
Preliminary analysis of breath samples using VOCAM Plus identified a consistent VOC profile distinguishing heartworm-infected from uninfected dogs.
On April 1, 2026, the Board of Directors (the “Board”) of Global Innovative Platforms Inc. (the “Company”) appointed the following individuals to serve as directors of the Company, effective immediately:
On April 1, 2026, the Board of Directors (the “Board”) of Global Innovative Platforms Inc. (the “Company”) appointed the following individuals to serve as directors of the Company, effective immediately:
On April 1, 2026, the Board of Directors (the “Board”) of Global Innovative Platforms Inc. (the “Company”) appointed the following individuals to serve as directors of the Company, effective immediately:
On April 1, 2026, the Board of Directors (the “Board”) of Global Innovative Platforms Inc. (the “Company”) appointed the following individuals to serve as directors of the Company, effective immediately:
Max materiality 0.65 · Median 0.35 · Most common event other_material